163 related articles for article (PubMed ID: 36473425)
1. Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes and neonatal morbidities in preterm infants.
Wendel K; Aas MF; Gunnarsdottir G; Rossholt ME; Bratlie M; Nordvik T; Landsend ECS; Fugelseth D; Domellöf M; Pripp AH; Stiris T; Moltu SJ
Clin Nutr; 2023 Jan; 42(1):22-28. PubMed ID: 36473425
[TBL] [Abstract][Full Text] [Related]
2. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
3. Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.
Marc I; Boutin A; Pronovost E; Perez Herrera NM; Guillot M; Bergeron F; Moore L; Sullivan TR; Lavoie PM; Makrides M
JAMA Netw Open; 2023 Mar; 6(3):e233934. PubMed ID: 36943265
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic and docosahexaenoic acid supplementation and brain maturation in preterm infants; a double blind RCT.
Moltu SJ; Nordvik T; Rossholt ME; Wendel K; Chawla M; Server A; Gunnarsdottir G; Pripp AH; Domellöf M; Bratlie M; Aas M; Hüppi PS; Lapillonne A; Beyer MK; Stiris T; Maximov II; Geier O; Pfeiffer H
Clin Nutr; 2024 Jan; 43(1):176-186. PubMed ID: 38061271
[TBL] [Abstract][Full Text] [Related]
5. Effect of arachidonic and docosahexaenoic acid supplementation on quality of growth in preterm infants: A secondary analysis of a randomized controlled trial.
Rossholt ME; Bratlie M; Wendel K; Aas MF; Gunnarsdottir G; Fugelseth D; Pripp AH; Domellöf M; Størdal K; Stiris T; Moltu SJ
Clin Nutr; 2023 Dec; 42(12):2311-2319. PubMed ID: 37856920
[TBL] [Abstract][Full Text] [Related]
6. Effects of nutrition therapy on growth, inflammation and metabolism in immature infants: a study protocol of a double-blind randomized controlled trial (ImNuT).
Wendel K; Pfeiffer HCV; Fugelseth DM; Nestaas E; Domellöf M; Skålhegg BS; Elgstøen KBP; Rootwelt H; Pettersen RD; Pripp AH; Stiris T; Moltu SJ;
BMC Pediatr; 2021 Jan; 21(1):19. PubMed ID: 33407269
[TBL] [Abstract][Full Text] [Related]
7. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
8. Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial.
Wendel K; Gunnarsdottir G; Fossan Aas M; Westvik ÅS; Pripp AH; Fugelseth D; Stiris T; Moltu SJ
Neonatology; 2023; 120(4):465-472. PubMed ID: 37121228
[TBL] [Abstract][Full Text] [Related]
9. Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants.
Wackernagel D; Nilsson AK; Sjöbom U; Hellström A; Klevebro S; Hansen-Pupp I
Prostaglandins Leukot Essent Fatty Acids; 2024 Feb; 201():102613. PubMed ID: 38377640
[TBL] [Abstract][Full Text] [Related]
10. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
11. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.
Marc I; Lavoie PM; McPhee AJ; Collins CT; Simonyan D; Pronovost E; Guillot M; Gould JF; Mohamed I; Beltempo M; Boutin A; Fortier I; Sullivan TR; Moore L; Makrides M
BMJ Open; 2023 Jul; 13(7):e076223. PubMed ID: 37518076
[TBL] [Abstract][Full Text] [Related]
12. Randomized Controlled Trial of Early Docosahexaenoic Acid and Arachidonic Acid Enteral Supplementation in Very Low Birth Weight Infants.
Frost BL; Patel AL; Robinson DT; Berseth CL; Cooper T; Caplan M
J Pediatr; 2021 May; 232():23-30.e1. PubMed ID: 33358843
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
Tanaka K; Tanaka S; Shah N; Ota E; Namba F
J Matern Fetal Neonatal Med; 2022 May; 35(9):1730-1738. PubMed ID: 32456494
[TBL] [Abstract][Full Text] [Related]
14. Lung function in preterm infants at 3 months corrected age after neonatal LC-PUFA supplementation.
Wendel K; Rossholt ME; Gunnarsdottir G; Aas MF; Westvik ÅS; Pripp AH; Carlsen KCL; Fugelseth D; Stiris T; Moltu SJ
Pediatr Pulmonol; 2024 Feb; 59(2):389-398. PubMed ID: 37975489
[TBL] [Abstract][Full Text] [Related]
15. High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis.
Marc I; Boutin A; Pronovost E; Guillot M; Bergeron F; Moore L; Makrides M
BMJ Open; 2022 Oct; 12(10):e064515. PubMed ID: 36253040
[TBL] [Abstract][Full Text] [Related]
16. Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm.
Sullivan TR; Gould JF; Bednarz JM; McPhee AJ; Gibson R; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Davis PG; Simmer K; Collins CT; Doyle LW; Makrides M
JAMA Netw Open; 2023 Jun; 6(6):e2317870. PubMed ID: 37294565
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants.
Collins CT; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS; Travadi J; Berry MJ; Liley HG; Opie GF; Tan K; Lui K; Morris SA; Stack J; Stark MJ; Chua MC; Jayagobi PA; Holberton J; Bolisetty S; Callander IR; Harris DL; Gibson RA
N Engl J Med; 2017 Mar; 376(13):1245-1255. PubMed ID: 28355511
[TBL] [Abstract][Full Text] [Related]
18. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial.
Sjöbom U; Andersson MX; Pivodic A; Lund AM; Vanpee M; Hansen-Pupp I; Ley D; Wackernagel D; Sävman K; Smith LEH; Löfqvist C; Hellström A; Nilsson AK
Clin Nutr; 2023 Jun; 42(6):962-971. PubMed ID: 37120902
[TBL] [Abstract][Full Text] [Related]
19. Use of SMOF lipid emulsion in very preterm infants does not affect the incidence of bronchopulmonary dysplasia-free survival.
Ndiaye ABKT; Mohamed I; Pronovost E; Angoa G; Piedboeuf B; Lemyre B; Afifi J; Qureshi M; Sériès T; Guillot M; Simonyan D; Yusuf K; Lavoie PM; Fraser WD; Mâsse B; Nuyt AM; Lacaze-Masmonteil T; Marc I
JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1892-1902. PubMed ID: 35403244
[TBL] [Abstract][Full Text] [Related]
20. Enteral long-chain polyunsaturated fatty acids and necrotizing enterocolitis: A systematic review and meta-analysis.
Alshaikh BN; Reyes Loredo A; Yusuf K; Maarouf A; Fenton TR; Momin S
Am J Clin Nutr; 2023 May; 117(5):918-929. PubMed ID: 37137615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
